| Financial Year |
March 31 2023 |
| Monetary Funds |
309,774,245.41 |
| Held-for-trading Financial Assets |
108,849,671.87 |
| Notes Receivable |
2,857,525.00 |
| Accounts Receivable |
209,680,399.47 |
| Advances to Suppliers |
32,427,142.93 |
| Other Receivables |
7,673,513.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
276,993,648.22 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
17,978,461.76 |
| Total Current Assets |
975,256,411.09 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
56,616,738.66 |
| Investment Properties |
5,960,062.82 |
| Fixed Assetes |
223,775,119.00 |
| Under-construction Projects |
78,890,854.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
79,323,116.13 |
| R&D expenses |
-- |
| Goodwill |
188,795,770.48 |
| Long-Term Deferred and Prepaid Expenses |
7,547,288.46 |
| Deferred Income Tax Assets |
14,143,383.87 |
| Other Non-Current Assets |
14,915,974.66 |
| Sub-Total of Non-Current Assets |
699,193,471.51 |
| Total Assets |
1,674,449,882.60 |
| Short-Term Loans |
3,003,804.17 |
| Trading Financial liabilities |
-- |
| Notes Payable |
4,131,550.72 |
| Accounts Payable |
60,792,204.78 |
| Accounts Received In Advance |
668,308.00 |
| Employee Compensation Payable |
6,340,322.24 |
| Taxes Payable |
3,265,115.75 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
97,220,250.69 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,016,089.61 |
| Other Current Liabilities |
1,261,028.30 |
| Sub-Total of Current Liabilities |
253,686,145.82 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
3,890,667.03 |
| Other Non-Current Liabilities |
233,562.00 |
| Sub-Total of Non-Current Liabilities |
28,080,144.75 |
| Total Liabilities |
281,766,290.57 |
| Paid-In Capital(Or Share Stock) |
99,834,751.00 |
| Capital Surplus |
981,961,137.89 |
| Surplus Reserve |
30,528,557.53 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
221,313,104.16 |
| Minority Stockholder's Interest |
58,519,031.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,334,164,560.73 |
| Owner's Equity（Stockholder's Equity） |
1,392,683,592.03 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,674,449,882.60 |
